ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY

Bibliografske podrobnosti
Main Authors:	Collin, S, Metcalfe, C, Donovan, J, Lane, J, Neal, D, Hamdy, F, Davis, M, Martin, R
Format:	Journal article
Izdano:	2009

Podobne knjige/članki

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
od: Collin, S, et al.
Izdano: (2009)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
od: Turner, E, et al.
Izdano: (2011)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
od: Hamdy, F, et al.
Izdano: (2006)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
od: Hamdy, F, et al.
Izdano: (2006)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
od: Rosario, D, et al.
Izdano: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
od: Rosario, D, et al.
Izdano: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
od: Rosario, D, et al.
Izdano: (2012)

The protect (prostate testing for cancer and treatment) study: Advanced cases found through a UK screening study
od: Neal, D, et al.
Izdano: (2006)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
od: Lane, J, et al.
Izdano: (2010)

Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
od: Brindle, L, et al.
Izdano: (2006)

Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial.
od: Lane, J, et al.
Izdano: (2007)

Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT study.
od: Zuccolo, L, et al.
Izdano: (2013)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
od: Macefield, R, et al.
Izdano: (2009)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
od: Down, L, et al.
Izdano: (2011)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
od: Down, L, et al.
Izdano: (2011)

Association of obesity with prostate cancer: A case-control study within the population-based PSA testing phase of the ProtecT study
od: Dimitropoulou, P, et al.
Izdano: (2011)

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study.
od: Dimitropoulou, P, et al.
Izdano: (2011)

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.
od: Moore, A, et al.
Izdano: (2009)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
od: Lane, J, et al.
Izdano: (2007)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
od: Rosario, D, et al.
Izdano: (2008)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
od: Lane, J, et al.
Izdano: (2009)

The value of repeat serum PSA measurements in the detection of prostate cancer - Experience from the feasibility phase of the UK protect study
od: Hamdy, F, et al.
Izdano: (2006)

Screening for prostate cancer. The case against.
od: Donovan, J, et al.
Izdano: (2005)

Prostate cancer: screening approaches.
od: Donovan, J, et al.
Izdano: (2005)

Prostate cancer: screening approaches
od: Donovan, J, et al.
Izdano: (2005)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
od: Avery, K, et al.
Izdano: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
od: Avery, K, et al.
Izdano: (2012)

10-year outcomes in localized prostate cancer.
od: Hamdy, F, et al.
Izdano: (2017)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
od: Lane, J, et al.
Izdano: (2004)

Estimating the sensitivity of a prostate cancer screening programme for different PSA cut-off levels: A UK case study
od: Leal, J, et al.
Izdano: (2018)

Screening for prostate cancer remains controversial.
od: Neal, D, et al.
Izdano: (2009)

Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
od: Collin, S, et al.
Izdano: (2010)

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study.
od: Burton, A, et al.
Izdano: (2013)

PTGS2-899G>C and prostate cancer risk: a population-based nested case-control study (ProtecT) and a systematic review with meta-analysis.
od: Murad, A, et al.
Izdano: (2009)

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
od: J. Donovan, et al.
Izdano: (2003-01-01)

10-year outcomes in localized prostate cancer: Authors' reply
od: Hamdy, F, et al.
Izdano: (2017)

Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
od: Lane, A, et al.
Izdano: (2016)

Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis.
od: Collin, S, et al.
Izdano: (2009)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
od: Avery, K, et al.
Izdano: (2007)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
od: Harrison, S, et al.
Izdano: (2020)